ANKHD1 divergent transcript (ANKHD1-DT)

ANKHD1 divergent transcript (ANKHD1-DT) is a long non-coding RNA originating from the ANKHD1 locus, running opposite (divergent) to the coding strand of the ANKHD1 gene. Unlike its protein-coding counterpart ANKHD1—which encodes a multidomain protein involved in cell cycle regulation, cell proliferation, and cancer progression[1][2][3]—ANKHD1-DT lacks protein-coding capacity and is presumed to function through RNA-mediated mechanisms, such as chromatin remodeling, transcriptional regulation, or acting as a molecular scaffold for regulatory complexes. There is emerging evidence of differential expression of ANKHD1-DT or related non-coding RNA isoforms in various cancers, including potential correlations with proliferation or metastasis, but its precise biological functions and mechanisms remain poorly defined[7]. It is not recognized as a directly druggable target, receptor, or therapeutic enzyme. Key context and supporting details: - ANKHD1 (not ANKHD1-DT) is a protein with ankyrin repeats and a KH domain, playing roles in cell proliferation and cancer, and is sometimes described as MASK or MASK-BP3 in the literature[1][2][3][5][6]. - The ANKHD1-DT lncRNA is separate from the well-characterized ANKHD1 protein; the "divergent transcript" typically designates a non-coding RNA transcribed from the opposite (divergent) direction at a locus[7]. - There is no evidence that ANKHD1-DT serves as a receptor, enzyme, transporter, or classical drug target, nor is it known to be bound by drugs or used as a biomarker for patient selection or efficacy monitoring. - Reports referring to splice variants such as ANKHD1-BP3 or MASK-BP3 relate to protein-coding or fusion forms, not to the lncRNA ANKHD1-DT[5][7]. If your intended query was about the protein-coding ANKHD1 or its readthrough variants (e.g., ANKHD1-EIF4EBP3 fusion, MASK-BP3), these are involved in cellular processes and cancer and may have more clearly defined functional roles and potential as therapeutic targets[1][6][7]. However, for "ANKHD1 divergent transcript", available evidence supports its identification as a lncRNA with unclear or emerging biological and clinical significance.

Other names

ANKHD1-DT